839 TALLTM (Targeted Antigen Loaded Liposomes) immunotherapy exploits recall immunity to form an excellent co-therapy option for immune checkpoint inhibitors
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797630824921694208 |
|---|---|
| author | Amanda G Powell Indu Venugopal Morgan N DeLong Shelby Knoche Michael J McGuire Kathlynn C Brown |
| author_facet | Amanda G Powell Indu Venugopal Morgan N DeLong Shelby Knoche Michael J McGuire Kathlynn C Brown |
| author_sort | Amanda G Powell |
| collection | DOAJ |
| first_indexed | 2024-03-11T11:13:17Z |
| format | Article |
| id | doaj.art-40acf51381124d558c8c3695758c8c84 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T11:13:17Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-40acf51381124d558c8c3695758c8c842023-11-11T10:35:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0839839 TALLTM (Targeted Antigen Loaded Liposomes) immunotherapy exploits recall immunity to form an excellent co-therapy option for immune checkpoint inhibitorsAmanda G Powell0Indu Venugopal1Morgan N DeLong2Shelby Knoche3Michael J McGuire4Kathlynn C Brown5Medicine, Boston University, Boston, Massachusetts, USASRI International, Harrisonburg, VA, USASRI International, Harrisonburg, VA, USASRI International, Harrisonburg, VA, USASRI International, Harrisonburg, VA, USASRI International, Harrisonburg, VA, USA |
| spellingShingle | Amanda G Powell Indu Venugopal Morgan N DeLong Shelby Knoche Michael J McGuire Kathlynn C Brown 839 TALLTM (Targeted Antigen Loaded Liposomes) immunotherapy exploits recall immunity to form an excellent co-therapy option for immune checkpoint inhibitors Journal for ImmunoTherapy of Cancer |
| title | 839 TALLTM (Targeted Antigen Loaded Liposomes) immunotherapy exploits recall immunity to form an excellent co-therapy option for immune checkpoint inhibitors |
| title_full | 839 TALLTM (Targeted Antigen Loaded Liposomes) immunotherapy exploits recall immunity to form an excellent co-therapy option for immune checkpoint inhibitors |
| title_fullStr | 839 TALLTM (Targeted Antigen Loaded Liposomes) immunotherapy exploits recall immunity to form an excellent co-therapy option for immune checkpoint inhibitors |
| title_full_unstemmed | 839 TALLTM (Targeted Antigen Loaded Liposomes) immunotherapy exploits recall immunity to form an excellent co-therapy option for immune checkpoint inhibitors |
| title_short | 839 TALLTM (Targeted Antigen Loaded Liposomes) immunotherapy exploits recall immunity to form an excellent co-therapy option for immune checkpoint inhibitors |
| title_sort | 839 talltm targeted antigen loaded liposomes immunotherapy exploits recall immunity to form an excellent co therapy option for immune checkpoint inhibitors |
| work_keys_str_mv | AT amandagpowell 839talltmtargetedantigenloadedliposomesimmunotherapyexploitsrecallimmunitytoformanexcellentcotherapyoptionforimmunecheckpointinhibitors AT induvenugopal 839talltmtargetedantigenloadedliposomesimmunotherapyexploitsrecallimmunitytoformanexcellentcotherapyoptionforimmunecheckpointinhibitors AT morganndelong 839talltmtargetedantigenloadedliposomesimmunotherapyexploitsrecallimmunitytoformanexcellentcotherapyoptionforimmunecheckpointinhibitors AT shelbyknoche 839talltmtargetedantigenloadedliposomesimmunotherapyexploitsrecallimmunitytoformanexcellentcotherapyoptionforimmunecheckpointinhibitors AT michaeljmcguire 839talltmtargetedantigenloadedliposomesimmunotherapyexploitsrecallimmunitytoformanexcellentcotherapyoptionforimmunecheckpointinhibitors AT kathlynncbrown 839talltmtargetedantigenloadedliposomesimmunotherapyexploitsrecallimmunitytoformanexcellentcotherapyoptionforimmunecheckpointinhibitors |